Sex-specific metabolic pathways were associated with alzheimer's disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
-
Xu, Jin (King's College London)
;
Green, Becki (King's College London) ;
Kim, Min (Steno Diabetes Center Copenhaguen) ;
Lord, Jodie (King's College London) ;
Ebshiana, Amera (King's College London) ;
Westwood, Sarah (University of Oxford. Department of Psychiatry) ;
Baird, Alison (University of Oxford. Department of Psychiatry) ;
Nevado-Holgado, Alejo (University of Oxford. Department of Psychiatry) ;
Shi, Liu (University of Oxford. Department of Psychiatry) ;
Hye, Abdul (King's College London) ;
Snowden, Stuart (King's College London) ;
Bos, Isabelle (Maastricht University (Països Baixos)) ;
Vos, Stephanie J.B (Maastricht University (Països Baixos)) ;
Vandenberghe, Rik (VU University Medical Center. Alzheimer Center (Països Baixos)) ;
Teunissen, Charlotte E. (VU University Medical Center. Department of Radiology and Nuclear Medicine (Països Baixos)) ;
Kate, Mara Ten (VU University Medical Center. Department of Radiology and Nuclear Medicine (Països Baixos)) ;
Scheltens, Philip (VU University Medical Center (Països Baixos)) ;
Gabel, Silvy (University Hospitals Leuven (Bèlgica)) ;
Meersmans, Karen (University Hospitals Leuven (Bèlgica)) ;
Blin, Olivier (Aix-Marseille Université (França)) ;
Richardson, Jill (GlaxoSmithKline R&D (Regne Unit)) ;
De Roeck, Ellen E. (University of Antwerp (Països Baixos)) ;
Engelborghs, Sebastiaan (University of Antwerp (Països Baixos)) ;
Sleegers, Kristel (Complex Genetics of Alzheimer's Disease Group. VIB Center for Molecular Neurology. VIB) ;
Bordet, Régis (Université de Lille. Department of Medical Pharmacology) ;
Rami Gonzalez, Lorena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Kettunen, Petronella (University of Gothenburg) ;
Tsolaki, Magda (AHEPA University Hospital (Grècia)) ;
Verhey, Frans R. J. (Maastricht University. Alzheimer Centrum Limburg (Països Baixos)) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Peyratout, Gwendoline (Lausanne University Hospital) ;
Tainta, Mikel (Fundación CITA-Alzhéimer Fundazioa) ;
Johannsen, Peter (Danish Dementia Research Centre. Rigshospitalet) ;
Freund-Levi, Yvonne (King's College London) ;
Froelich, Lutz (University of Heidelberg. Department of Geriatric Psychiatry (Alemanya)) ;
Dobricic, Valerija (University of Lübeck. Institutes of Neurogenetics and Cardiogenetics) ;
Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ;
Molinuevo, José Luis (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Wallin, Anders (Sahlgrenska Academy at University of Gothenburg (Suècia)) ;
Popp, Julius (University Hospital of Psychiatry Zürich (Suïssa)) ;
Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa (San Sebastián, País Basc)) ;
Bertram, Lars (University of Oslo. Department of Psychology) ;
Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Streffer, Johannes (University of Antwerp (Països Baixos)) ;
Visser, Pieter Jelle (Maastricht University. Alzheimer Centrum Limburg (Països Baixos)) ;
Lovestone, Simon (King's College London) ;
Proitsi, Petroula (King's College London) ;
Legido-Quigley, Cristina (King's College London. Institute of Pharmaceutical Science) ;
Universitat Autònoma de Barcelona
Subscribe to this discussion. You will then receive all new comments by email.
guest ::
